Latest News
01-Dec-2022 Max Health Tops Manipal’s AMRI Bid by ₹900 cr
30-Nov-2022 Gland Pharma Acquires Cenexi Grp for € 120 m
30-Nov-2022 Govt Asks Court to Dismiss Vax Death Case
29-Nov-2022 Bharat Bio’s Intranasal Vax Approved as Booster Dose
28-Nov-2022 Medley-Cipla Deal Talks Called off Over Valuation Issues
  more...
Latest Reports
Nov-22 Specialty Chemicals - Motilal Oswal  
Nov-22 Sharp decline in volume for Oct-22 - Emkay Research  
Oct-22 Margins remain under pressure; revenue growth to recover - Nirmal Bang  
Oct-22 Jul-Sep'22 Earnings Preview - Prabhudas Lilladher  
Sep-22 Brand matters - Nirmal Bang  
  more...

Quarterly Summary September-2022
Desc Current Previous Per.Chg
Sales 29160.3 26052.3 11.9
Otherincome 757.7 1041.6 -27.3
Expense 21540.6 19688.0 9.4
RawMaterial 9242.2 8692.6 6.3
StaffCost 3762.1 3431.5 9.6
ExciseDuty 0.0 0.0 -100.0
OtherExp 6589.9 5859.8 12.5
Interest 371.7 353.0 5.3
GrossProfit 8569.5 7210.3 18.9
Depreciation 1525.8 1339.7 13.9
Tax 1610.4 1260.4 27.8
NetProfit 5398.4 5071.1 6.5
Total.Comp 50 -- --
Source: ETIG Database

Sectoral Companies As on 1 Dec 2022
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 251002.77
Divi's Lab 90790.54
Cipla 90756.81
Dr.Reddy's 74462.96
Torrent Phar 55571.85
Abbott (I) 43652.07
Zydus Life 42104.78
Alkem Labora 37406.00
Lupin 35038.49
Biocon 34277.13
Gland Pharma 28863.68
Aurobindo Ph 27469.92
Syngene Intl 24406.94
  click here for the complete list